This retrospective study has shown a reduction in hospitalization for cardiac failure in patients who were already using statins receiving anthracycline and trastuzumab in the context of breast cancer.   The study was to be presented during the ACC 2020 scientific sessions together with the World Congress of Cardiology. However, it had to be called off…